The significance of high hemoglobin A1 (HbA1) levels (≥8.0%) found in 12.1% of 648 individuals with normal glucose tolerance constituting a part of a representative population sample was examined. Measurement error in HbA1 and/or glucose-tolerance levels was precluded by HbA1 remaining in the same range over 3.5 yr in 89.7% of 29 individuals with initially high and 68.1% of 22 individuals with initially low (<6.5%) HbA1. Rate of deterioration to glucose intolerance (6.9%) in the high group during that period resembled the rate (11.8%) in a control group (n = 279). Fasting plasma glucose significantly accounted for only 2.4% of total HbA1 - population variance. No correlation of HbA1 was found with other correlates of glucose tolerance or with daily caloric intake and physical activity. A small but significant increment in HbA1 was associated with smoking (7.1 vs. 6.8%, P < .01) and with clinically overt atherosclerosis (7.3 vs. 6.9%, P < .01). We conclude that factors unrelated to glucose metabolism are the main determinants of HbA1 level in normal glucose tolerance and play an important role in diabetes as well. These factors have bearing on evaluation of diabetic control by HbA1 and possibly on risk for diabetic complications.
Skip Nav Destination
Article navigation
Original Articles|
May 01 1988
Significance of High HbA1 Levels in Normal Glucose Tolerance
Michaela Modan, MSc;
Michaela Modan, MSc
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Dina Meytes, MD;
Dina Meytes, MD
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Paul Rozeman, MD;
Paul Rozeman, MD
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Shaul Ben Yosef, MD;
Shaul Ben Yosef, MD
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Ephraim Sehayek, MD;
Ephraim Sehayek, MD
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Nurit Ben Yosef, BSc;
Nurit Ben Yosef, BSc
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Ayala Lusky, MSc;
Ayala Lusky, MSc
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Hillel Halkin, MD
Hillel Halkin, MD
Departments of Clinical Epidemiology, and of Medicine, Chaim Sheba Medical Center, Tel Hashomer, and the Department of Hematology, Edith Wolfson Hospital
Holon
; affiliated with the Tel Aviv University Sackler School of Medicine
Tel Aviv, Israel
Search for other works by this author on:
Address correspondence and reprint requests to Michaela Modan, Head, Biometry Unit, Department of Clinical Epidemiology, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel.
Citation
Michaela Modan, Dina Meytes, Paul Rozeman, Shaul Ben Yosef, Ephraim Sehayek, Nurit Ben Yosef, Ayala Lusky, Hillel Halkin; Significance of High HbA1 Levels in Normal Glucose Tolerance. Diabetes Care 1 May 1988; 11 (5): 422–428. https://doi.org/10.2337/diacare.11.5.422
Download citation file: